Amante, Romain J. http://orcid.org/0000-0001-5468-7168
Auf der Maur, Priska http://orcid.org/0000-0002-9059-8979
Richina, Veronica http://orcid.org/0000-0003-4616-2657
Sethi, Atul
Iesmantavicius, Vytautas
Bonenfant, Debora
Aceto, Nicola
Bentires-Alj, Mohamed http://orcid.org/0000-0001-6344-1127
Funding for this research was provided by:
SystemsX.ch
European Research Council (694033 STEM-BCPC)
Swiss National Science Foundation
Novartis
Krebsliga Beider Basel
Krebsliga Schweiz
Swiss Personalised Health Network
Department of Surgery of the University Hospital Basel
University of Basel
Article History
Received: 24 August 2021
Accepted: 29 May 2022
First Online: 23 June 2022
Declarations
: D.B. is a full-time employee of Monte Rosa Therapeutics. R.J.A is a full-time employee of Novartis Pharma A.G. M.B.-A. owns equities in and has received laboratory support and compensation from Novartis, and serves as consultant for Basilea. M.B.-A. is an Editorial Board Member of the Journal of Mammary Gland Research and Neoplasia.